home / stock / dcph / dcph quote
Last: | $15.73 |
---|---|
Change Percent: | -1.25% |
Open: | $15.37 |
Close: | $15.73 |
High: | $16.17 |
Low: | $15.25 |
Volume: | 879,944 |
Last Trade Date Time: | 03/28/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$15.73 | $15.37 | $15.73 | $16.17 | $15.25 | 879,944 | 03-28-2024 |
$15.18 | $15.03 | $15.18 | $15.2 | $14.74 | 333,248 | 03-27-2024 |
$14.82 | $15.46 | $14.82 | $15.5 | $14.79 | 309,046 | 03-26-2024 |
$15.3 | $15.34 | $15.3 | $15.605 | $15.25 | 333,463 | 03-25-2024 |
$15.23 | $15.55 | $15.23 | $15.63 | $15.23 | 251,874 | 03-22-2024 |
$15.5 | $15.82 | $15.5 | $16.09 | $15.48 | 435,758 | 03-21-2024 |
$15.75 | $15 | $15.75 | $15.84 | $15 | 501,177 | 03-20-2024 |
$14.97 | $14.92 | $14.97 | $15.48 | $14.86 | 724,569 | 03-19-2024 |
$14.85 | $15.55 | $14.85 | $15.72 | $14.65 | 729,274 | 03-18-2024 |
$15.59 | $15.83 | $15.59 | $16.49 | $15.55 | 1,596,745 | 03-15-2024 |
$15.91 | $15.8 | $15.91 | $16.15 | $15.57 | 537,810 | 03-14-2024 |
$15.98 | $16.3 | $15.98 | $16.48 | $15.78 | 458,103 | 03-13-2024 |
$16.09 | $16.49 | $16.09 | $16.61 | $16.08 | 514,661 | 03-12-2024 |
$16.54 | $17.07 | $16.54 | $17.3 | $16.43 | 506,568 | 03-11-2024 |
$16.94 | $17.06 | $16.94 | $17.27 | $16.68 | 243,316 | 03-08-2024 |
$16.93 | $17.05 | $16.93 | $17.14 | $16.78 | 479,940 | 03-07-2024 |
$16.93 | $16.92 | $16.93 | $17.07 | $16.74 | 317,379 | 03-06-2024 |
$16.8 | $16.63 | $16.8 | $16.86 | $16.465 | 316,820 | 03-05-2024 |
$16.61 | $17.42 | $16.61 | $17.42 | $16.33 | 578,378 | 03-04-2024 |
$17.36 | $16.81 | $17.36 | $17.73 | $16.74 | 950,660 | 03-01-2024 |
News, Short Squeeze, Breakout and More Instantly...
Deciphera Pharmaceuticals Inc. Company Name:
DCPH Stock Symbol:
NASDAQ Market:
2024-03-21 19:56:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-03-11 17:52:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
– Fourth Quarter 2023 Total Revenue of $48.3 Million and Full Year 2023 Revenue of $163.4 Million; QINLOCK ® Net Product Revenue Increased 27% to $159.1 Million in 2023 Compared to 2022 – – Expects to Submit NDA for Vimseltinib in the Second Quarter of 20...